Silver Book Fact

Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.

Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman. Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics. Health Affairs. 2007; 26(1): 62-74

Reference

Title
Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman
Volume & Issue
Volume 26, Issue 1
Pages
62-74

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • From 1999-2000, average blood pressures for Americans age 40 and older would have been 10-13% higher without antihypertensive drug therapy.  
  • According to the Pharmaceutical Research and Manufacturers of America, 146 new medicines are being developed for heart disease and stroke. They include 17 for stroke, 16 for congestive heart failure,…  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • Echocardiography and nuclear imaging are used for provocative “stress” testing of the heart. When combined with other forms of stress, both can identify the presence of coronary artery-obstructing lesions that…